NCT04305639 The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)" Status COMPLETED Phase N/A
NCT04297683 HEALEY ALS Platform Trial - Master Protocol Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04288856 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE1
NCT04259255 Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) Status COMPLETED Phase N/A
NCT04257760 Evaluation of Palliative Care for Patients With ALS and Their Caregivers Status COMPLETED Phase NA
NCT04248465 An Efficacy and Safety Study of Ravulizumab in ALS Participants Status TERMINATED Phase PHASE3
NCT04245709 Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT04240925 Tolerability, Safety and Efficacy of Sigh Breaths During NIMV in Motor Neuron Disease Status UNKNOWN Phase NA
NCT04233099 Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS) Status COMPLETED Phase N/A
NCT04226144 Breath Stacking Technique Associated With Expiratory Muscle Training in Amyotrophic Lateral Sclerosis Patients Status TERMINATED Phase NA
NCT04172792 Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE1
NCT04165850 Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS Status COMPLETED Phase PHASE2
NCT04140136 The Efficacy and Safety of Vitamin E Mixed Tocotrienols In Patients With Amyotrophic Lateral Sclerosis (ALS) Status UNKNOWN Phase PHASE2
NCT04098406 Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT04097158 Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone Status RECRUITING Phase N/A